Atlas Trials

Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients

Clinical trial NCT06182917 · UNKNOWN

Trial details

NCT number
NCT06182917
Sponsor
West China Second University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Ovarian Cancer
Start date
2023-10-01
Primary completion
2025-12-30
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.